课题基金 / 基金详情

PHOTOPHYSICS OF PHOTODYNAMIC THERAPY

PHOTOPHYSICS OF PHOTODYNAMIC THERAPY
光动力疗法的光物理学
批准号:
6362598
负责人:
THOMAS Harrison FOSTER
金额:
$27.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-07-01 至 2003-02-28

项目摘要

项目成果

THOMAS Harrison FOSTER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The recent approvals of Photofrin-sensitized photodynamic therapy (PDT) in Canada and the Netherlands are significant events in the history of this relatively new cancer therapy. These developments will encourage further research in the design, synthesis, and evaluation of new photo- sensitizing agents, which seek to overcome certain limitations of the first generation prophyrins. Among these generally recognized limitations are weak absorption at wavelengths where optical penetration in tissue is optimal, relatively poor specificity with respect to tumor and normal tissue uptake and retention, and prolonged skin photosensitivity. A number of candidate 'second generation' compounds have been proposed and studied. The focus of these proposed studies is a family of cationic dyes that show particular promise as sensitizers of direct tumor cell destruction for PDT. Initial experience with the use of these compounds, described as Nile Blue derivatives, raises interesting and challenging research problems that are critical to resolve in order to optimize the effectiveness of these photosensitizers. Furthermore, these questions are likely to be of general importance in the search for optimum PDT methods of targeting tumor cells directly. On the basis of a body of experimental and theoretical work carries out in our laboratory over the past several years, we hypothesize that problems associated with photochemical oxygen consumption and diffusion will be critical aspects of optimizing the use of the Nile Blue derivatives for PDT. These issues are particularly important for these dyes in that they are bleached through enzymatic and photoreduction mechanisms under conditions of low oxygen concentration. Careful attention to the details of these processes can create significant opportunities for improved therapeutic efficacy. Towards this end, the application poses fives specific aims: (1) direct microelectrode measurements of PDT-induced oxygen consumption in Nile blue-sensitized multicell tumor spheroids and determination of photodynamic rates of oxygen consumption; (2) determination of the threshold dose for these dyes in the multicell tumor spheroid system; (3) optical sectioning (confocal) fluorescence microscopy of Nile blue-sensitized spheroids under various incubation conditions and during irradiation to determine bleaching rates and mechanisms; (4 optical reflectance spectroscopy of tumor oxygenation during Nile blue-sensitized PDT with emphasis on hemoglobin O2 saturation and cytochrome redox status; and (5) optimization of Nile blue-sensitized PDT irradiation protocols in three rodent tumor systems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optics
  • 批准号:
    8230227
  • 项目类别:
  • 资助金额:
    $15.48万
  • 财政年份:
    2011
  • 负责人:
    THOMAS Harrison FOSTER
  • 依托单位:
Optics
  • 批准号:
    7611650
  • 项目类别:
  • 资助金额:
    $19.41万
  • 财政年份:
    2008
  • 负责人:
    THOMAS Harrison FOSTER
  • 依托单位:
Optical Dosimetry for Clinical Trials of Pc 4 Photodynamic Therapy
  • 批准号:
    7844929
  • 项目类别:
  • 资助金额:
    $24.2万
  • 财政年份:
    2006
  • 负责人:
    THOMAS Harrison FOSTER
  • 依托单位:
Optical Dosimetry for Clinical Trials of Pc 4 Photodynamic Therapy
  • 批准号:
    7254804
  • 项目类别:
  • 资助金额:
    $24.2万
  • 财政年份:
    2006
  • 负责人:
    THOMAS Harrison FOSTER
  • 依托单位:
海外基金